194 related articles for article (PubMed ID: 36980940)
1. A Case Report of a Feto-Placental Mosaicism Involving a Segmental Aneuploidy: A Challenge for Genome Wide Screening by Non-Invasive Prenatal Testing of Cell-Free DNA in Maternal Plasma.
De Falco L; Vitiello G; Savarese G; Suero T; Ruggiero R; Savarese P; Ianniello M; Petrillo N; Bruno M; Legnante A; Passaretti FF; Ardisia C; Di Spiezio Sardo A; Fico A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980940
[TBL] [Abstract][Full Text] [Related]
2. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.
Li X; Ju D; Shi Y; Li Y; Dong H; Huang J; Zhang Y
Medicine (Baltimore); 2020 Jul; 99(29):e20848. PubMed ID: 32702826
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling.
Feresin A; Stampalija T; Cappellani S; Bussani R; Faletra F; Murru F; Ulivi S; Suergiu S; Savarese P; Pedicini A; Policicchio M; Ruggiero R; Bosio B; Savarese G; Ardisia C
Front Genet; 2022; 13():982508. PubMed ID: 36386832
[TBL] [Abstract][Full Text] [Related]
4. Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism.
Chen CP; Tsai C; Lin MH; Chern SR; Chen SW; Lai ST; Chen WL; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2017 Oct; 56(5):691-693. PubMed ID: 29037560
[TBL] [Abstract][Full Text] [Related]
5. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
[TBL] [Abstract][Full Text] [Related]
6. Low-level mosaic trisomy 2 at amniocentesis in a pregnancy associated with positive NIPT and CVS results for trisomy 2, maternal uniparental disomy 2, perinatal progressive decrease of the aneuploid cell line, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, intrauterine growth restriction and a favorable fetal outcome.
Chen CP; Wu FT; Chern SR; Wu PS; Pan YT; Lee CC; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2023 Jul; 62(4):571-576. PubMed ID: 37407197
[TBL] [Abstract][Full Text] [Related]
7. [Prenatal cytogenetic and molecular genetic analysis of a fetus with confined placenta mosaicism for trisomy 16].
Jiao Z; Zhu C; Hou Y; Wang L; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):771-774. PubMed ID: 34365622
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Cytogenetic and Molecular Cytogenetic Outcomes of Cell-Free DNA Testing for Rare Chromosomal Anomalies.
Basaran S; Has R; Kalelioglu IH; Sarac Sivrikoz T; Karaman B; Kirgiz M; Dehgan T; Kalayci T; Ozsait Selcuk B; Miny P; Yuksel A
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553656
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis and molecular cytogenetic characterization of a de novo deletion of 4q34.1→qter associated with low PAPP-A and low PlGF in the first-trimester maternal serum screening, congenital heart defect on fetal ultrasound and a false negative non-invasive prenatal testing (NIPT) result.
Chen CP; Chen SW; Wang LK; Chern SR; Wu PS; Wu FT; Chen LF; Wang W
Taiwan J Obstet Gynecol; 2022 Nov; 61(6):1039-1043. PubMed ID: 36427970
[TBL] [Abstract][Full Text] [Related]
10. Mosaic trisomy 16 at amniocentesis in a pregnancy associated with positive non-invasive prenatal testing for trisomy 16, placental trisomy 16, intrauterine growth restriction, intrauterine fetal death, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, and prenatal progressive decrease of the aneuploid cell line.
Chen CP; Wu FT; Chen YY; Pan YT; Wu PS; Lee MS; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2023 Jul; 62(4):597-601. PubMed ID: 37407203
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Detection of Trisomy 2: Considerations for Genetic Counseling and Testing.
Talantova OE; Koltsova AS; Tikhonov AV; Pendina AA; Malysheva OV; Tarasenko OA; Vashukova ES; Shabanova ES; Golubeva AV; Chiryaeva OG; Glotov AS; Bespalova ON; Efimova OA
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107671
[TBL] [Abstract][Full Text] [Related]
12. Low-level mosaic trisomy 13 at amniocentesis in a pregnancy associated with a positive NIPT result suspicious of trisomy 13, a CVS result of mosaic trisomy 13, cytogenetic discrepancy in various tissues and a favorable fetal outcome.
Chen CP; Chen M; Ma GC; Chang SP; Wu FT; Pan YT; Chern SR; Chen WL; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2023 Jul; 62(4):577-581. PubMed ID: 37407198
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between Non-invasive Prenatal Genetic Testing (NIPT) and Amniotic Chromosomal Test due to Placental Mosaicism: A Case Report and Literature Review.
Hayata K; Hiramatsu Y; Masuyama H; Eto E; Mitsui T; Tamada S
Acta Med Okayama; 2017 Apr; 71(2):181-185. PubMed ID: 28420901
[TBL] [Abstract][Full Text] [Related]
14. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency.
Xie X; Zhou H; Zhao Q; Lu Y; Meng Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482
[TBL] [Abstract][Full Text] [Related]
15. High-level mosaicism for 45,X in 45,X/46,X,+mar at amniocentesis in a pregnancy associated with positive non-invasive prenatal testing for Turner syndrome, normal male external genitalia and positive SRY in the fetus, a favorable fetal outcome, postnatal decrease of the 45,X cell line and cytogenetic discrepancy in various tissues.
Chen CP; Wu FT; Pan YT; Lee CC; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2023 Sep; 62(5):749-753. PubMed ID: 37679007
[TBL] [Abstract][Full Text] [Related]
16. Deletion rescue resulting in segmental homozygosity: A mechanism underlying discordant NIPT results.
Caldwell S; Sagaser K; Nelson Z; Frey J; Wardrop J; Boomer T; McCullough R; Schwartz S
Am J Med Genet A; 2020 Nov; 182(11):2666-2670. PubMed ID: 32798301
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
18. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.
Lau TK; Jiang FM; Stevenson RJ; Lo TK; Chan LW; Chan MK; Lo PS; Wang W; Zhang HY; Chen F; Choy KW
Prenat Diagn; 2013 Jun; 33(6):602-8. PubMed ID: 23553438
[TBL] [Abstract][Full Text] [Related]
19. Low-level mosaic trisomy 9 at amniocentesis associated with a positive non-invasive prenatal testing for trisomy 9, maternal uniparental disomy 9, intrauterine growth restriction and a favorable fetal outcome in a pregnancy.
Chen CP; Ko TM; Chen SW; Chern SR; Wu FT; Pan YT; Pan CW; Chen YY; Wang W
Taiwan J Obstet Gynecol; 2023 May; 62(3):457-460. PubMed ID: 37188454
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and Molecular Investigations detect a Mosaic Variant of Turner Syndrome only Suspected by Non-Invasive Prenatal Testing: Two Case Reports with Negative Ultrasound Examinations.
Libotte F; Carpineto SL; Dello Russo C; Viola A; Margiotti K; Restaldi F; Novelli A; Mesoraca A; Giorlandino C
J Med Life; 2020; 13(4):624-628. PubMed ID: 33456614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
